Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
VC that helps founders build defensible moats|Mike Zajko,Partner,Lattice
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Previously the head of new token listings at CoinList
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Pursuit Minerals Advances Lithium Projects in Argentina
00:10:00
Understanding Interviews vs. Engagement Centers at BHP
00:10:00
Alticast's Role in Today's Changing PayTV Industry | Tae-Hoon Kim, CEO, Alticast CorpA085810:KOE
00:10:00
From Chemical Engineering to Financial Planning at Illuminate Wealth Management | Ben Hockema, Founder, Illuminate Wealth Management.
00:10:00
Frederick W. Davidson CEO at Impact Silver Corp.
00:10:00
Polar Capital Technology Trust Plc - Pioneering Technology-Focused Investment Strategies for Long-Term Growth
00:10:00
Our CEO, Chris Kubasik, sat down with Squawk on the Street's Morgan Brennan to discuss our $4.7 billion acquisition of Aerojet Rocketdyne.|Ms. Eileen P. Drake has served as Chief Executive Officer and President of Aerojet Rocketdyne Holdings, Inc.,
00:10:00
Continental Gold: Pioneering Modern-Day Large-Scale Gold Mining in Colombia
00:10:00
Investigating Hydrogen Technology at Ampol | Steven Gregg, Chairman, Ampol LtdALD:NZC
00:10:00
"Market Recovery in Sight: 2024 Outlook from Jeff Krumpelman of Mariner Wealth Advisors | Jeff Krumpelman - Chief Investment Strategist, Mariner Wealth Advisors"
00:10:00
Exploring Uganda's Cobalt Potential: M2 Cobalt's Promising Path Forward
00:10:00
Unveiling Africa's Economic Potential: A Conversation with Tony Elumelu | Tony Elumelu, Founder, Heirs Holdings.